atropine (CBT-009)
/ Cloudbreak Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 27, 2023
Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop
(clinicaltrials.gov)
- P1/2 | N=84 | Completed | Sponsor: Cloudbreak Therapeutics, LLC | Not yet recruiting ➔ Completed
Trial completion • Ophthalmology
1 to 1
Of
1
Go to page
1